- Neu
E-Book, Englisch, 311 Seiten
Reihe: PublishDrive
Cesar / Martins / Nogueira Bioactive Compounds and Phytotherapy
1. Auflage 2026
ISBN: 978-65-5675-896-1
Verlag: PublishDrive
Format: EPUB
Kopierschutz: 0 - No protection
Evidence and Practical Applications
E-Book, Englisch, 311 Seiten
Reihe: PublishDrive
ISBN: 978-65-5675-896-1
Verlag: PublishDrive
Format: EPUB
Kopierschutz: 0 - No protection
Bioactive Compounds in Foods and Phytotherapy: Evidence and Practical Applications addresses, in a clear and accessible manner, the fundamentals and therapeutic applications of bioactive substances found in foods and medicinal plants. The book explores the history of both traditional and scientific use of bioactive compounds, covering their classification, mechanisms of action, and potential human health benefits, while also highlighting risks, adverse effects, and necessary precautions regarding supplementation and phytotherapy. In this context, the work presents-simply, clearly, and didactically-key aspects related to phenolic compounds, carotenoids, vitamins, and minerals, among others, as well as the medicinal plants most frequently used in clinical practice. It discusses the criteria for safety, efficacy, and regulation of phytotherapy for various healthcare professionals authorized to prescribe such treatments-in accordance with the guidelines of their respective professional regulatory bodies-along with the implications for their therapeutic use. The text emphasizes the importance of tailoring prescriptions to the individual, understanding potential interactions, and leveraging up-to-date scientific evidence to support safe and effective clinical approaches. Recommendations for use, pharmaceutical forms, and strategies for responsible prescribing are also addressed through practical examples. Designed to facilitate understanding for professionals, students, and others interested in the subject, the book outlines key topics, concepts, and definitions, and incorporates reflections and examples throughout its 12 chapters.
Autoren/Hrsg.
Weitere Infos & Material
Chapter 1. History and Legislation of Bioactive Compounds in Foods (BCF)
Aline Veroneze de Mello Cesar
Key Topics of the Chapter
- Studies on food composition have undergone four revolutions: the recognition that foods provide energy, the characterization of vitamins and minerals, the establishment of associations between diet and disease, and the discovery of substances in functional foods—including bioactive compounds and antinutritional factors—that also influence human health.
- Foods are substances that provide the elements necessary for the human body’s formation, maintenance, and development. Nutrients, which originate from foods of both plant and animal origin, can be classified into macronutrients and micronutrients.
- Bioactive compounds exert specific metabolic or physiological effects within the human body and can be distinguished from nutrients by the absence of a recommended minimum intake; moreover, their deficiency does not cause deficiency diseases as is the case with nutrients. Functional foods are those that resemble conventional foods in appearance, are consumed as part of a regular diet, and have demonstrated physiological benefits and/or a reduction in the risk of chronic diseases, beyond their basic nutritional functions.
- Principal legislations: RDC Nos. 17 and 18 of 1999, 2/2002, 54/2012, and 243/2018 from ANVISA, and Technical Note No. 64/2024/SEI/COPAR/GGALI/DIRE2/ANVISA.
Greetings, dear reader, we shall now explore the topic of bioactive compounds, which may appear to be a recent subject, yet it is not. What accounts for this? Historical records from ancient civilizations, including Egyptian, Greco-Roman, and Chinese cultures, demonstrate an established interest in the identification and use of bioactive compounds, especially those applied for therapeutic purposes (Piccirillo; Amaral, 2018).
To facilitate a clearer understanding, we proceed with the definitions:
- Foods are substances that supply the human organism with elements necessary to its formation, maintenance, and development. They consist of chemical components also essential to human metabolism, providing energy or contributing to growth, development, and the preservation of health and life. (Mahan; Arlin, 1995). They are classified according to their origin, which may be plant-based (cereals, legumes, feculents, vegetables, mushrooms, fruits, vegetable fats, sugarcane and its derivatives, and condiments) or animal (meat, offal and viscera, milk and dairy products, eggs, animal fats, and honey) (Macedo; Matos, 2015).
- Nutrients are derived from foods of both plant and animal origin and can be classified as macronutrients (carbohydrates, proteins, and lipids), so named due to their higher requirement (in grams) and their nature as large molecules that require hydrolysis; and as micronutrients (vitamins and minerals), so named due to their lower requirement (generally in milligrams or micrograms). In contrast to macronutrients, they do not supply energy but are essential for the metabolism of macronutrients and biochemical reactions that support growth, development, and the proper functioning of the organism (Mahan; Arlin, 1995).
- In practical terms, the bioactive compounds in foods are considered nutrients or non-nutrients normally consumed as components of a food, which possess specific metabolic or physiological actions in the human organism.
The difference between a nutrient and a bioactive compound is important and may be somewhat subtle. Let us begin with nutrients, such as vitamins and minerals (micronutrients), which are essential for the human organism. They have well-defined functions and, when consumed in insufficient quantities, deficiencies may occur, potentially leading to the development of diseases (Pimentel; Elias; Philippi, 2019). A clear example of this is vitamin D, as its deficiency can cause rickets in children.
Concepts and Definitions
Rickets: a disease occurring in childhood, characterized by impaired development and mineralization of bones.
Bioactive compounds (whether nutrients or not) are substances that, although present in foods, do not have a recommended minimum intake for the organism; that is, their deficiency does not lead to deficiency diseases as observed with nutrients (Pimentel; Elias; Philippi, 2019). They are not considered essential, yet they possess the capacity to positively influence the body's functioning, aiding in the improvement or optimization of pre-existing physiological functions. In other words, while nutrients are essential for specific physiological functions, bioactive compounds act to enhance bodily functions, thereby conferring additional health benefits.
To effectively reach this discovery, studies on food composition underwent four major revolutions. The first evolution was the identification that foods provide energy. Next came the characterization of vitamins and minerals, which proved crucial for preventing diseases resulting from their deficiency. The third revolution established associations between diet and diseases, including those related to malnutrition and Non-Communicable Diseases (NCDs). The fourth revolution – which is our focus – involved the discovery of substances in functional foods that also influence human health, such as bioactive compounds and antinutritional factors (Dwyer, 1994).
In this regard, since bioactive compounds are substances present in foods, Japan was the first country to introduce the term “functional foods” in the mid-1980s, as well as the first to establish a specific regulatory framework for functional foods (Araya; Lutz, 2003). What definition did they propose? Functional foods are those similar in appearance to conventional foods, consumed as part of a regular diet, and that have demonstrated physiological benefits and/or the ability to reduce the risk of chronic diseases, in addition to their fundamental nutritional functions (Araya; Lutz, 2003).
When considering bioactive compounds and their relation to food regulation, it is fundamental to understand the legislative framework governing this field in Brazil. These regulations ensure both consumer safety and transparency of information on product labels. In Brazil, this history dates back to the 1990s.
It is important to highlight that, in Brazil, there is no legal definition of the concept of functional food. However, the concept of ‘functional property claim’ and ‘health claim’ is recognized, with ‘functional’ claims being directly associated with the physiological roles in growth, development, and normal organism functions, as well as claims regarding general health maintenance and reduction of disease risk, optionally (Stringheta , 2007).
In 1999, Resolutions No. 17 and 18 were issued by ANVISA, the regulatory agency in Brazil. Resolution No. 17, dated April 30, 1999, approved the technical regulation that establishes the fundamental guidelines for food risk and safety assessment, whereby the agency evaluates whether the food may contain substances harmful to health, requests reliable data on the long-term impact of food consumption, and defines a systematic process to assess and minimize risks. Imagine that a company intends to launch a new plant extract possessing antioxidant properties. First and foremost, it must demonstrate that the consumption of this ingredient will not pose health risks, in accordance with the criteria set forth by RDC No. 17/1999.
After ensuring the safety of the ingredient, the next step is to scientifically demonstrate the functional or health benefits it confers, which is why Resolution No. 17 is associated with No. 18, dated April 30, 1999. This RDC approved the technical regulation that establishes the fundamental guidelines for the analysis and substantiation of functional and/or health properties claimed on food labeling. For example, if a company intends to claim that a food 'supports cholesterol reduction,' how can the veracity and safety of this assertion be assured? The RDC established a set of rules to guarantee that such claims may only be made if they are scientifically substantiated; consequently, the company must present robust studies to support them.
This resolution dealt precisely with the claims made by manufacturers on food labels, such as “helps control cholesterol” or “strengthening the immune system,” establishing guidelines to ensure they are scientifically substantiated. That is, to include a claim on the label, it is necessary to present studies demonstrating the efficacy of the food or ingredient.
In 2002, ANVISA published RDC No. 2/2002, which goes beyond safety and evidence of benefits, focusing on specific bioactive substances and isolated probiotics (Box 1.1). It defined a “bioactive substance” as one that, beyond nutrients, includes non-nutrients possessing specific metabolic or physiological activity, and classified which substances fall into this category; also defined “probiotics” as live microorganisms capable of improving the intestinal microbial balance, producing beneficial effects on the individual's health. Therefore, it specifies how these compounds may be utilized in foods, provided they comply with the safety and efficacy requirements established by the existing regulations. For instance, probiotics such as lactobacilli must be studied regarding the effective dose necessary to confer benefits to the intestinal microbiota, as well as to demonstrate that they do not cause...




